Heterologous Booster Dose with CORBEVAX following Primary Vaccination with COVISHIELD Enhances Protection against SARS-CoV-2

Despite effective vaccination programs, waning immunity in the vaccinated populations and the emergence of variants of concern posed a risk of breakthrough infections. A booster dose was demonstrated to provide substantially increased protection against symptomatic disease and hospitalization. We ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaggaiahgari, Shashidhar, Munigela, Apoorva, Mitnala, Sasikala, Gujjarlapudi, Deepika, Simhadri, Venu, D, Nageshwar Reddy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781398/
https://www.ncbi.nlm.nih.gov/pubmed/36560556
http://dx.doi.org/10.3390/vaccines10122146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781398/
https://www.ncbi.nlm.nih.gov/pubmed/36560556
http://dx.doi.org/10.3390/vaccines10122146

Ejemplares similares